Amgen Procrit 10,000 units/mL: Particulate Matter Risk
Amgen recalls Procrit (epoetin alfa) 10,000 units/mL vials due to glass flakes found during quality checks. Affected lots expire July 2018. No remedy specified in recall notice.
Recall notice
Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection.
Contact the company
What happened, in plain English
Amgen is recalling Procrit (epoetin alfa) vials that contain glass flakes. This could cause serious injury if injected. The recall affects specific lots with expiration dates through July 2018. Read more at govinfonow.com/recall/41256-amgen-procrit-10-000-units-ml-particulate-matter-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/41256-amgen-procrit-10-000-units-ml-particulate-matter-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-1173-2017
Cite this page
“Amgen Procrit 10,000 units/mL: Particulate Matter Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41256-amgen-procrit-10-000-units-ml-particulate-matter-risk. Based on FDA recall #D-1173-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1173-2017%22&limit=1).
Why it’s dangerous
Glass flakes were found in the vials during routine quality inspections. If injected, these particles could cause serious injury or death. The hazard is not described as causing immediate harm in normal use.
Who’s affected
Patients prescribed Procrit for anemia who have the specific lot numbers listed. Those using the product without proper quality checks are at risk.
How to tell if you have this one
Check for lot numbers G290530A (expiring July 2018) or G290531A (expiring July 2018) on the vial packaging. The product is sold in boxes of 6 or 25 single-use vials.
- Brand
Amgen- Category
Drug
What to do — step by step
Check Product Lot Number
Look for lot numbers G290530A or G290531A on the vial packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Amgen recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1173-2017 (September 13, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1173-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.